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Abstract
Objectives: To determine the prevalence and aetiology of systemic disease among patients requesting dental treat-
ment in public and private practice.
Study Design: A retrospective analysis was performed of the medical histories of 2000 patients requesting dental 
treatment during the year 2009. One thousand patients came from the Fontiñas Primary Care Oral and Dental 
Health Unit of the Galician Health Service (SERGAS), Spain, and the other thousand from a private clinic; both 
clinics were situated in Santiago de Compostela, La Coruña, Spain. The data collected were the following: demo-
graphic data (age and sex), presence or absence of systemic diseases and the nosologic categories, and drug history 
(type and number of drugs).
Results: The prevalence of systemic disease was significantly higher among patients seen in the public system 
(35.2% in the public system versus 28.1% in the private system; p= 0.003). The differences between the two sys-
tems were more marked when considering patients aged under 65 years, particularly with respect to rheumatic 
and endocrine-metabolic (diabetes) disorders. The prevalence of patients receiving polypharmacy (>4 drugs/day) 
was significantly higher among patients seen in the public system (5.7% in the public system versus 2.7% in the 
private system; p= 0.009).
Conclusions: There is a high prevalence of medical disorders and of patients receiving polypharmacy among 
individuals requesting dental care, particularly in the public health system. Dentists must have adequate training 
in medical disease and must be fully integrated into primary care health teams in order to prevent or adequately 
resolve complications.
Key words: Dentistry, medical history, systemic disease, polypharmacy.
Fernández-Feijoo J, Garea-Gorís R, Fernández-Varela M, Tomás-Carmo-
na I, Diniz-Freitas M, Limeres-Posse J. Prevalence of systemic diseases 
among patients requesting dental consultation in the public and private 
systems. Med Oral Patol Oral Cir Bucal. 2012 Jan 1;17 (1):e89-93.  
 http://www.medicinaoral.com/medoralfree01/v17i1/medoralv17i1p89.pdf
Article Number: 17313          http://www.medicinaoral.com/
© Medicina Oral S. L. C.I.F. B 96689336 - pISSN 1698-4447 - eISSN: 1698-6946
eMail:  medicina@medicinaoral.com 
Indexed in: 
Science Citation Index Expanded
Journal Citation Reports
Index Medicus, MEDLINE, PubMed
Scopus, Embase and Emcare 
Indice Médico Español
doi:10.4317/medoral.17313
http://dx.doi.org/doi:10.4317/medoral.17313
Med Oral Patol Oral Cir Bucal. 2012 Jan 1;17 (1):e89-93.                                                                                                                                                     Systemic Disease in Dental Consultations
e90
Introduction
The advances in Medicine in recent decades, particu-
larly with regard to early diagnosis and new therapeu-
tic procedures, have contributed to an improvement in 
the quality of life of patients with chronic illness and 
have increased life expectancy in the general popula-
tion. Spain is one of the countries of the European Com-
munity with the highest life expectancy (80.33 years in 
2005) (1). This situation is also seen in oral health, con-
tributing to the preservation of natural teeth until later 
in life, thus increasing the demand for dental treatment 
among elderly patients or those with concomitant dis-
eases (2,3).
Some apparently healthy patients requesting dental 
treatment may have serious systemic disease and may 
be taking drugs that can influence dental treatment (4). 
Healthcare professionals responsible for oral and den-
tal health of these patients must ensure that the risks of 
systemic complications during or as a result of dental 
treatment are minimised (4). Patients who come to den-
tal clinics do not always report their past medical his-
tory, usually because they do not consider it important 
or do not relate it to their dental problem. An adequate 
medical training and the taking of a detailed medical 
history, which must include the patient’s past medical 
and drug history, and interrogation about the general 
state of health, are essential in order to detect patients 
with relevant medical conditions and to avoid the risks 
derived from dental treatment. With the aim of stand-
ardising this information and identifying possible medi-
cal problems, authors such as Abraham-Inpijn et al. (5) 
recommend the systematic administration of validated 
questionnaires (for example, the European Medical Risk 
Related History Questionnaire) to patients requesting 
treatment in dental clinics.
In Spain there are very few studies that have evaluated 
systemic disease in patients receiving dental treatment 
(4,6). In addition, whilst the public system offers certain 
basic dental care for adults and has a specialist reference 
departments -Stomatology and Maxillofacial Surgery- 
for complex cases, the private system offers all types of 
dental treatment though it does not usually have a spe-
cialist reference structure. The objective of this study 
has been to determine the prevalence and nosologic 
categories of systemic disease among patients request-
ing dental treatment, comparing the findings from the 
public dental service and a private dental clinic.
Materials and Methods
A retrospective review was performed of the medi-
cal histories of the 2000 patients who most recently 
requested dental treatment during the year 2009; one 
thousand histories were retrieved from a primary care 
oral and dental health unit of the Galician Health Serv-
ice and 1000 from a private dental clinic; both clinics 
served an urban population in Santiago de Compostela, 
Galicia, Spain. The exclusion criterion was age less than 
18 years; this reduced the number of evaluable histories 
to 1625 (671 from primary care and 954 from private 
practice). The variables recorded for each patient were 
the following: sex, age, past history of systemic dis-
eases (the nosological categories used were cardiovas-
cular, gastrointestinal, neurological, psychiatric, rheu-
matological, endocrine-metabolic, and liver and kidney 
disease, disability, and others) and drug consumption 
(patients were considered to be receiving polypharmacy 
if they were regularly taking more than 4 drugs).
Statistical Analysis
The results were analysed using the SPSS statistical 
package version 15.0 for Windows (SPSS Inc., Chicago, 
Illinois, USA). Student’s t test was used to analyse age. 
Fisher’s exact test was used for the analysis of the vari-
ables sex, presence/absence of medical disease, nosolo-
gical categories, and presence/absence of drug admin-
istration. The Mann-Whitney U test was applied to ana-
lyse differences between the private and public health 
systems for the variable polypharmacy. A “p” value less 
than 0.05 was considered statistically significant.
Results
No statistically significant difference in the mean age 
was detected between patients in the public health system 
and private system (46.3±17.8 years and 45.7±17.5 years, 
respectively). In the public system, 35.2% of patients had 
some type of systemic disease compared to 28.1% of 
patients in the private clinic; this difference, which was 
statistically significant (p= 0.003), was due mainly to res-
piratory disease (3.7% in the public health system versus 
1.6% in private practice, p= 0.008) and endocrine-met-
abolic disease (13.7% in the public system versus 6.3% 
in private practice, p= 0.001). Although drug consump-
tion was similar in the two groups of patients (27% in 
the public system versus 23.3% in the private system), 
the percentage of patients receiving polypharmacy was 
significantly higher in the group from the public system 
(5.7% versus 2.7% in the private system, p= 0.009). These 
results are shown in (Table 1).
Patients were then subdivided according to age (<65 
years and ≥65 years). In patients under 65 years, we de-
tected significant differences in the prevalence of sys-
temic disease depending on the origin: 25.9% among 
patients in the public system and 17.6% among those 
from the private system (p= 0.001); this difference was 
due mainly to endocrine-metabolic disease (8.4% in the 
public system versus 3.6% in the private system, p= 
0.001) and rheumatological disease (4.2% in the pub-
lic system versus 2.2% in the private system, p= 0.034) 
(Table 2). In patients of 65 years or older, there was no 
statistically significant difference in the presence or 
absence of systemic disease between patients in the 
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public health service and those seen in private practice; 
however, on analysis of the different nosological cat-
egories, we found that patients from the public health 
system presented a higher prevalence of respiratory 
tract diseases (7.2% in the public system versus 1.2% in 
the private system, p= 0.011) and endocrine-metabolic 
diseases (36.8% in the public system versus 19% in the 
private system, p= 0.001) (Table 3).
Among patients under 65 years of age, drug consump-
tion was significantly higher in those from the public 
health service (25.9%) than in those from the private 
system (17.6%) (p= 0.001). The percentage of patients 
receiving polypharmacy was also significantly higher 
among those requesting dental treatment in the public 
health system (3.1% in the public system versus 0.8% in 
the private system, p= 0.001).
In the study population of 65 years or older, medication 
was being taken by similar proportions in the two health 
systems (public, 76%; private, 77.4%). In addition, there 
were no statistically significant differences in the per-
centage of patients receiving polypharmacy (16.8% in 
the public system versus 11.9% in the private system).
Discussion
In the literature, the state of health of individuals request-
ing dental care is most commonly evaluated through the 
PUBLIC SYSTEM 
(n=671) 
PRIVATE SYSTEM 
(n=954) P
                     Age 46.3±17.8 years 45.7±17.5 years 0.468 
             Sex: 
Female 
Male 
57.6 % 
42.4 % 
58.4% 
41.6% 0.760 
Systemic disease 35.2 %             28.1% 0.003 
Cardiovascular disease 16.1 %             14.7 % 0.442 
Gastrointestinal disease 1.6% 1.2% 0.514 
Neurological disease  2.1 % 2.2% 1.000 
Psychiatric disease  5.4 %               5 % 0.820 
Rheumatic disease  6.9 %  5.3 % 0.242 
Respiratory disease  3.7 % 1.6% 0.008 
Endocrine and metabolic disease 13.7 %  6.3 % 0.000 
Liver or kidney disease   4.2 %  2.6 % 0.09 
Disability  0.7% 1.3% 0.459 
Other diseases  2.7 %  1.7 % 0.217 
Drug consumption 27% 23.3% 0.089 
Polypharmacy 5.7%  2.7% 0.009 
PUBLIC SYSTEM 
(n=503) 
PRIVATE SYSTEM 
(n=742) P
Systemic disease 25.9% 17.6% 0.000 
Cardiovascular disease 7.9 % 5.6 % 0.114 
Gastrointestinal disease 2% 1.1 % 0.252 
Neurological disease 1.8 % 1.9 % 1.000 
Psychiatric disease 4.6% 3.1 % 0.182 
Rheumatic disease 4.2 % 2.2 % 0.034 
Respiratory disease 2.9 % 1.7 % 0.129 
Endocrine and metabolic disease 8.4 % 3.6 % 0.000 
Liver or kidney disease 2.2 % 1.4 % 0.291 
Disability 0.7 % 1.0 % 0.771 
Other diseases 2 % 1.5 % 0.527 
Drug consumption 25.9 % 17.6 % 0.000 
Polypharmacy 3.1 % 0.8 % 0.001 
Table 1. Age, sex, prevalence of systemic disease, and drug consumption among patients in the public and 
private health systems.
Table 2. Prevalence of systemic disease and drug consumption among patients aged less than 65 years in 
the public and private health systems.
Med Oral Patol Oral Cir Bucal. 2012 Jan 1;17 (1):e89-93.                                                                                                                                                     Systemic Disease in Dental Consultations
e92
use of self-administered questionnaires that gather in-
formation on various aspects of health. However, these 
questionnaires have certain limitations: they require pa-
tient collaboration, they must be drawn up in a language 
that the patient understands, and they require confirma-
tion of the replies by the dentist (7,8). Other authors 
have used a modified American Society of Anesthesiol-
ogy (ASA) risk score (a method designed by the ASA in 
the middle of the past century to determine the risk of 
patients undergoing general anaesthesia) to determine 
the risk of dental patients treated under local anaesthe-
sia (9,10). The objective of the present study was not to 
detect previously undiagnosed systemic disease but to 
evaluate the prevalence of known pre-existing systemic 
disease in a cohort of patients requesting dental treat-
ment; we therefore used the medical histories drawn up 
by a single dentist.
The prevalence of systemic disease in patients in the 
study group was similar to that detected by other au-
thors, both in patients from the public system (11,12) 
and in those from private practice (2,4,13). The majority 
of diseases were of cardiovascular origin, particularly 
systemic hypertension (HT), as reported in previous 
studies (4,6, 12-15); this is compatible with the report 
of the National Health Survey from 2006 (16), which 
stated that HT was the most prevalent chronic or long-
standing problem or disease diagnosed by doctors in 
individuals over 16 years of age in Spain. Fernández-
Feijoo et al.  (17), in a screening study for HT performed 
in a public health system dental clinic, found that 29.2% 
of patients requesting dental treatment had blood pres-
sure levels suggestive of HT. This high prevalence may 
have been due to the fact that the authors measured the 
blood pressure in all patients, thus detecting patients 
who had not previously been diagnosed; in the present 
study, information was obtained from the medical his-
tories, and we therefore only considered known hyper-
tensive patients.
The prevalence of systemic disease among patients 
from the public health system was greater than among 
those from private practice. In the literature, the ma-
jority of studies of similar characteristics to ours were 
performed in university centres (4,6,12); the only study 
conducted on patients receiving periodontal treatment 
in a private clinic, a public university centre, or a hos-
pital centre (situated in Milwaukee, Wisconsin, USA) 
was conducted by Nery et al. (13). Those authors also 
detected a higher prevalence of systemic disease among 
patients treated in the public centre.
In Spain, the difference in prevalence of systemic dis-
ease between public and private health systems is due 
mainly to a higher frequency of respiratory disease 
(particularly chronic obstructive pulmonary disease 
[COPD]) and endocrine-metabolic disease (particular-
ly diabetes). A possible explanation for this finding is 
that in the primary care service where this study was 
performed, there was a chronic-diseases follow-up unit 
(diabetes, HT, COPD), in which oral health assessments 
formed part of the health education offered to these 
patients, favouring more frequent visits to the public 
dental clinic by patients with oral or dental health prob-
lems. Taking into account that some of these diseases 
have specific, early, and/or particularly aggressive oral 
manifestations (e.g., periodontal disease in diabetes), 
this could explain the higher prevalence of these disease 
categories in patients under 65 years requesting dental 
care in the public health system.
It is estimated that 75% of individuals over 55 years of 
age are taking some form of drug that contributes to 
maintaining their vital functions (18). As the number of 
drugs that a patient is taking rises, the risk of interac-
tions between those drugs and medication commonly 
PUBLIC SYSTEM 
(n=125) 
PRIVATE SYSTEM 
(n=168) P
Systemic disease 76% 77.4% 0.782 
Cardiovascular disease 52 % 57.1 % 0.407 
Gastrointestinal disease 0 % 1.2 % 0.509 
Neurological disease 3.2 % 3.6 % 1.000 
Psychiatric disease 8.8 % 14.3 % 0.202 
Rheumatic disease 18.4 % 20.2 % 0.766 
Respiratory disease 7.2 % 1.2 % 0.011 
Endocrine and metabolic disease 36.8 % 19 % 0.001 
Liver or kidney disease 12.8 % 8.3 % 0.245 
Disability 0.8 % 2.4 % 0.398 
Other diseases 5.6 % 2.4 % 0.214 
Drug consumption 76 % 77.4 % 0.782 
Polypharmacy 16.8% 11.9% 0.060 
Table 3. Prevalence of systemic disease and drug consumption among patients aged 65 years or older in 
the public and private health systems.
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prescribed in dental practice increases (18). Our results 
regarding drug consumption among patients in public 
or private practice agree with those reported by other 
authors (4,19). However, the figures reported by Amado 
Cuesta et al. (6) and by Valderrama et al. (20) were no-
ticeably higher; this was due to the fact that their study 
populations were formed only of individuals over 65 
years of age and, as is widely recognised, the prevalence 
of medical disease and drug use increases with the age 
of the population (21), as was observed in our series.
Carter et al. (22), in a study in which they evaluated 
drug consumption among patients requesting dental 
treatment during the period 1984-2005, confirmed that 
there was a progressive increase in polypharmacy with 
age. In the literature, it has been shown that polyphar-
macy is more common in the population over 65 years 
of age (6,20); this was also observed in our study. The 
higher prevalence of patients under 65 years of age re-
ceiving polypharmacy in the public health service could 
be explained by the fact that the percentage of patients 
with systemic disease (particularly diabetes) in this 
age range was higher among users of the public health 
service. Furthermore, it may be speculated that dentists 
in private practice could be unwilling to treat patients 
receiving polypharmacy, arguing that the public health 
system has specialist reference departments for com-
plex cases, or that patients themselves take this decision 
as they may consider that the public health system has 
more means to resolve any medical complication that 
may arise during dental treatment.
Although medical emergencies are rare in dental prac-
tice (23,24), they can occur during or as a consequence 
of a dental procedure and they may have a fatal out-
come. The results of our study confirm that there is a 
significant prevalence of patients with medical disorders 
and who are receiving polypharmacy among individu-
als requesting dental treatment; this particularly affects 
the public health service. As a result, we believe it is 
essential that dentists have adequate training in medical 
pathology and that they are fully integrated into prima-
ry care health teams in order to prevent complications 
or resolve them should they develop.
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